Farmgen Fenofibrate Tablet 160 mg
Fenofibrate 160mg
Tablet · Prescription medication
Farmgen Science Co., Ltd.
MFDS item code 202003558 · Approved 2020.05.15
This product's status changed to Expired on 2025.05.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of primary hyperlipidemia (including hypercholesterolemia and mixed dyslipidemia)
This medication is used for primary hyperlipidemia, specifically hypercholesterolemia (Type IIa), mixed hypercholesterolemia and hypertriglyceridemia (Types IIb and III), and hypertriglyceridemia (Type IV). It helps control blood lipid levels, thereby reducing the risk of cardiovascular disease.
Adults: Administer 160 mg of fenofibrate orally once daily immediately after a meal. Fenofibrate must be administered in combination with dietary therapy. This medicine may be less well absorbed on an empty stomach; therefore, administer immediately after a meal (except for the 145 mg formulation). Elderly patients: Dose reduction is generally not necessary if renal function is not reduced. Patients with renal impairment: Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine level 2.5 mg/dL or higher).
Pediatric patients: Clinical data on the use of this medicine in pediatric patients are not yet available.
This drug should not be used in patients with impaired liver function. Patients with moderate to severe renal impairment may experience muscle damage leading to rhabdomyolysis upon taking this medication, thus it should not be administered. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this drug. Patients who have had allergic reactions to this drug or its components should refrain from using it. Patients with gallbladder disease or a history of gallstones should also avoid this medication. Patients who have experienced photosensitivity reactions while taking fibrate-class medications or ketoprofen should not use this drug. This medication should not be administered to children. Patients with biliary cirrhosis or pancreatitis should avoid this drug. Additionally, this medication contains lactose and is not suitable for patients with lactose intolerance or specific genetic metabolic disorders. Patients with mild renal impairment or a history of it should reduce the dosage or extend the dosing interval while carefully monitoring renal function. Patients with liver function abnormalities or a history of liver issues should undergo frequent liver function tests. Patients with hypoalbuminemia or a history of gallstones should exercise caution. Patients taking anticoagulant medications or concurrently using statins may have an increased risk of side effects and should use this drug with caution. The elderly are more likely to have decreased hepatic and renal function, thus should use this medication with increased caution. This drug can affect the liver and biliary system, leading to elevated liver enzyme levels or the occurrence of gallstones and cholestatic hepatitis. Skin reactions such as rashes, itching, and photosensitivity may occur, and, rarely, hair loss can happen. Neurological symptoms such as dizziness, headaches, and fatigue may be reported. There is a risk of thrombus formation, and if muscle pain, cramps, or elevated muscle enzyme levels occur, medical consultation should be sought immediately. Gastrointestinal symptoms may include abdominal pain, nausea, vomiting, and diarrhea, and pancreatitis can occur rarely. Respiratory and hematological abnormalities may also happen occasionally, requiring immediate medical attention for any unusual symptoms. Regular blood tests and liver function tests should be conducted while taking this medication, and treatment can be discontinued if there is no therapeutic effect. If gallstones are suspected, gallbladder examination should be performed, and if stones are found, medication use should be halted. This drug may interact with other medications, particularly statins, anticoagulants, antidiabetic drugs, uric acid treatments, oral contraceptives, and hepatotoxic drugs, and caution is advised when used concurrently with these. Particularly with statins, the risk of muscle damage is heightened, so co-administration is generally not recommended. Women who are pregnant or may become pregnant and nursing mothers should refrain from taking this drug, as should those who are breastfeeding. This drug is not for use in children, and the elderly should take it with caution while regularly monitoring liver and kidney function. In cases of overdose, there is no specific antidote, so prescribed dosages should always be adhered to, and it is not removed by hemodialysis. This drug should be kept out of reach of children and not transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature, avoiding excessively hot or cold places.
White, rectangular film-coated tablet
100 tablets/box [(10 tablets/PTP X 10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fenofibrate 160mg
Tablet · Prescription medication
Farmgen Science Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Yu Yeong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.